Virbac
Giuliano Nigro is a Biochemistry R&D Platform Lead at Virbac since October 2022, where responsibilities include designing and managing a lab-scale platform for antibody production and spearheading vaccine development initiatives. Previously, Nigro served as a researcher at the Toulouse Biotechnology Institute from September 2020 to August 2022, focusing on novel biophysical assays and optimizing microbial fermentation processes. As a PhD student at École Polytechnique from October 2016 to December 2019, Nigro enhanced enzyme stability and contributed to high-impact publications. Early experience includes an internship at Institut Pasteur and a researcher position at the Institute of Cancer Therapeutics. Academic qualifications encompass a PhD in Biochemistry from École Polytechnique, a Master's degree in Biotechnology from Université de Technologie de Compiègne, and a Master's degree in Chemical Engineering, along with a Bachelor's degree in Chemistry.
Previous companies
This person is not in any teams
This person is not in any offices
Virbac
2 followers
Virbac provides innovative solutions to veterinarians, farmers, and animal owners in more than 100 countries around the world. Covering more than 50 species, their range of products and services enables them to diagnose, prevent and treat the majority of pathologies.